Binding and cell intoxication studies of anthrax lethal toxin

Molecular Biology Reports

Volumn 39, Issue 5, 2012, Pages 5897-5903

  Vuyisich, Momchilo ^a   Sanders, Claire K ^a   Graves, Steven W ^b  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Anthrax; Heptamer; Lethal toxin assembly; Protective antigen

Indexed keywords

ANTHRAX LETHAL TOXIN; ANTHRAX TOXIN; ANTHRAX TOXNIN RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG; ANTHRAX TOXIN RECEPTORS; BACTERIAL ANTIGEN; BACTERIAL TOXIN; IMMOBILIZED PROTEIN;

ANIMAL CELL; ANTHRAX; ANTIGEN SPECIFICITY; ARTICLE; BACILLUS ANTHRACIS; BINDING AFFINITY; BINDING ASSAY; CELL SURFACE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; DISSOCIATION CONSTANT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LD 50; MAMMAL CELL; MOUSE; NONHUMAN; OLIGOMERIZATION; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR BLOCKING; SURFACE PLASMON RESONANCE; ANIMAL; BIOLOGICAL MODEL; CELL LINE; CYTOLOGY; DRUG EFFECT; ISOLATION AND PURIFICATION; KINETICS; MACROPHAGE; METABOLISM; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE;

ANIMALIA; BACILLUS ANTHRACIS; MAMMALIA;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; CELL LINE; HUMANS; IMMOBILIZED PROTEINS; KINETICS; MACROPHAGES; MICE; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, PEPTIDE;

EID: 84863736166     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1401-2     Document Type: Article

References (26)

1. Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, Tapper M, Fisk TL, Zaki S, Popovic T, Meyer RF, Quinn CP, Harper SA, Fridkin SK, Sejvar JJ, Shepard CW, McConnell M, Guarner J, Shieh W-J, Malecki JM, Gerberding JL, Hughes JM, Perkins BA (2001) Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 7:933-944
2. Young JAT, Collier RJ (2007) Anthrax toxin: receptor binding, internalization, pore formation, and translocation. Annu Rev Biochem 76:17.11-17.23
3. Collier RJ, Young JAT (2003) Anthrax toxin. Ann Rev Cell Dev Biol 19:45-70
4. Tournier J-N, Quesnel-Hellmann A, Cleret A, Vidal DR (2007) Contribution of toxins to the pathogenesis of inhalational anthrax. Cell Microbiol 9:555-565
5. Bradley KA, Mogridge J, Mourez M, Collier RJ, Young JAT (2001) Identification of the cellular receptor for anthrax toxin. Nature 414:225-229
6. Scobie HM, Rainey GJA, Bradley KA, Young JAT (2003) Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. PNAS USA 100:5170-5174
7. Molloy SS, Bresnahan PA, Leppla SH, Klimpel KR, Thomas G (1992) Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem 267:16396-16402
8. Mogridge J, Cunningham K, Collier RJ (2002) Stoichiometry of Anthrax toxin complexes. Biochemistry 41:1079-1082
9. Karginov VA, Nestorovich EM, Moayeri M, Leppla SH, Bezrukov SM (2005) Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design. PNAS USA 102:15075-15080
10. Kassam A, Der SD, Mogridge J (2005) Differentiation of human monocytic cell lines confers susceptibility to Bacillus anthracis lethal toxin. Cell Microbiol 7:281-292
11. Singh Y, Leppla SH, Bhatnagar R, Friedlander AM (1989) Internalization and processing of Bacillus anthracis lethal toxin by toxin-sensitive and -resistant cells. J Biol Chem 264:11099-11102
12. Vick JA, Lincoln RE, Klein F, Mahlandt BG, Walker JS, Fish DC (1968) Neurological and physiological responses of the primate to anthrax toxin. J Infect Dis 118:85-96
13. Ezzell JW, Abshire TG (1992) Serum protease cleavage of Bacillus anthracis protective antigen. J Gen Microbiol 138:543-549
14. Panchal RG, Halverson KM, Ribot W, Lane D, Kenny T, Abshire TG, Ezzell JW, Hoover TA, Powell B, Little S, Kasianowicz JJ, Bavari S (2005) Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity. J Biol Chem 280:10834-10839
15. Chen Z, Moayeri M, Zhou Y-H, Leppla S, Emerson S, Sebrell A, Yu F, Svitel J, Schuck P, Claire MS, Purcell R (2006) Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen. J Infect Dis 193:625-633
16. Deshpande A, Hammon RJ, Sanders CK, Graves SW (2006) Quantitative analysis of the effect of cell type and cellular differentiation on protective antigen binding to human target cells. FEBS Lett 580:4172-4175
17. Miller CJ, Elliott JL, Collier RJ (1999) Anthrax protective antigen: prepore-to-pore conversion. Biochemistry 38:10432-10441
18. Mogridge J, Cunningham K, Lacy DB, Mourez M, Collier RJ (2002) The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen. PNAS USA 99: 7045-7048
19. Moayeri M, Wiggins JF, Leppla SH (2007) Anthrax protective antigen cleavage and clearance from the blood of mice and rats. Infect Immun (in pressr
20. Milne JC, Furlong D, Hanna PC, Wall JS, Collier RJ (1994) Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J Biol Chem 269:20607-20612
21. Elliott JL, Mogridge J, Collier RJ (2000)Aquantitative study of the interactions of Bacillus anthracis edema factor and lethal factor with activated protective antigen. Biochemistry 39:6706-6713
22. Vuyisich M, Gnanakaran S, Lovchik JA, Lyons CR, Gupta G (2008) A dual-purpose protein ligand for effective therapy and sensitive diagnosis of anthrax. Protein J 27:292-302
23. Kobiler D, Weiss S, Levy H, Fisher M, Mechaly A, Pass A, Alboum Z (2006) Protective antigen as a correlative marker for Anthrax in animal models. Infect Immun 74:5871-5876
24. Mabry R, Brasky K, Geiger R, Carrion R, Hubbard GB, Leppla S, Patterson JL, Georgiou G, Iverson BL (2006) Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays. Clin Vaccine Immun 13:671-677
25. Juris SJ, Melnyk RA, Bolcome RE, Chan J, Collier RJ (2007) Cross-linked forms of the isolated N-terminal domain of the lethal factor are potent inhibitors of anthrax toxin. Infect Immun 75:5052-5058
26. Komiyama T, Swanson JA, Fuller RS (2005) Protection from Anthrax Toxin-mediated killing of macrophages by the combined effects of furin inhibitors and chloroquine. Antimicrob Agents Chemother 49:3875-3882